Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
NEDERMAN HLDG AB | 5QR | Nov 14, 2024 | 18.86 | +3.29 |
Neinor Homes | 1NN | Nov 14, 2024 | 15.06 | -0.40 |
Nekkar | 0TT | Nov 14, 2024 | 0.82 | +4.59 |
Nektar Therapeutics | ITH | Nov 14, 2024 | 1.19 | -1.73 |
NEL | D7G | Nov 14, 2024 | 0.31 | +4.32 |
Nel ASA Unsponsored ADR (Norway) | D7GA | Nov 14, 2024 | 8.55 | -20.83 |
Nelly Group | CD20 | Nov 14, 2024 | 2.40 | -4.20 |
Nelnet, Inc. | NIJ | Nov 14, 2024 | 103.00 | +0.98 |
NEMETSCHEK UNSP.ADR/0,2 | NEM0 | Nov 14, 2024 | 19.50 | 0.00 |
Nemetschek SE | NEM | Nov 14, 2024 | 102.40 | +0.10 |
NENT Group B | NEB | Nov 14, 2024 | 0.05 | -0.55 |
Neo Performance Materials Inc | N14 | Nov 14, 2024 | 5.33 | +0.38 |
NEO-NEON | N2L | Nov 14, 2024 | 0.04 | +0.55 |
Neodecortech S.p.a. | FM2 | Nov 14, 2024 | 2.80 | -0.71 |
Neoen S.A. | N1N | Nov 14, 2024 | 39.06 | -0.26 |
NEOENERGIA UNSP.ADR 1 | 2Q40 | Nov 14, 2024 | 11.50 | 0.00 |
Neogen Corporation | NG2 | Nov 14, 2024 | 14.20 | 0.00 |
NeoGenomics, Inc. | NG9 | Nov 14, 2024 | 15.40 | +1.32 |
Neolife | 8JB | Nov 14, 2024 | 0.05 | +7.86 |
Neometals Ltd | 9R9 | Nov 14, 2024 | 0.05 | 0.00 |
NEOMETALS LTD SP.ADS/10 | 9R91 | Nov 14, 2024 | 0.44 | +1.37 |
NEON EQUITY NA O.N. | D77 | Nov 14, 2024 | 2.10 | 0.00 |
NeonMind Biosciences Inc | 6UF0 | Nov 14, 2024 | 0.00 | 0.00 |
Neosperience S.p.a | Y8E | Nov 14, 2024 | 0.68 | +1.19 |
NEOTECH METALS CORP. | V690 | Nov 14, 2024 | 0.08 | +2.56 |
Nephros | NPJP | Nov 14, 2024 | 1.52 | 0.00 |
Neptune Digital Assets Corp. | 1NW | Nov 14, 2024 | 0.64 | 0.00 |
Nerds On Site Inc | 3NS | Nov 14, 2024 | 0.03 | -10.34 |
Nerdwallet Inc | 6OI | Nov 14, 2024 | 13.80 | -4.17 |
NervGen Pharma Corp | 9UA | Nov 14, 2024 | 1.68 | -1.18 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.